We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AFP market cap is 232.8M. The company's latest EPS is NZD 0.1488 and P/E is 14.92.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Revenue | 105.6M | 113.11M | 130.31M | 156.64M | 195.41M |
| Operating Income | 21.21M | 10.71M | 20.39M | 19.67M | 24.24M |
| Net Income | 12.69M | 7.78M | 19.85M | 10.65M | 15.61M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Assets | 87.05M | 105.13M | 121.76M | 148.06M | 165.26M |
| Total Liabilities | 69.8M | 68.54M | 65.02M | 74.8M | 77.46M |
| Total Equity | 17.26M | 36.59M | 56.74M | 73.27M | 87.8M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Operating | 14.88M | 750k | 14.15M | 11.63M | 28.86M |
| Investing | -6.56M | -6.23M | -5.59M | -9.18M | -9.53M |
| Financing | -9.12M | 2.52M | -3.91M | -6.98M | -10.63M |
| Market Cap | 232.8M |
| Price to Earnings Ratio | 14.92 |
| Price to Sales Ratio | 1.19 |
| Price to Cash Ratio | 19.34 |
| Price to Book Ratio | 2.65 |
| Dividend Yield | 0.80% |
| Shares Outstanding | 104.87M |
| Average Volume (1 week) | 964 |
| Average Volume (1 Month) | 3.25k |
| 52 Week Change | -32.73% |
| 52 Week High | 3.53 |
| 52 Week Low | 2.15 |
| Spread (Intraday) | 0.4 (14.65%) |
| Company Name | AFT Pharmaceuticals Limited |
| Address |
level 1 auckland |
| Website | https://www.aftpharm.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
